Buttar Kulwant, Trigoboff Eileen, Grace Jeffery J
Dr. Buttar is with the Buffalo Psychiatric Center in Buffalo New York.
Dr. Trigoboff is with the School of Medicine Department of Psychiatry and the School of Pharmacy and Pharmaceutical Sciences at the State University of New York at Buffalo, and in private practice.
Innov Clin Neurosci. 2020 Oct 1;17(10-12):35-37. eCollection 2020 Oct-Dec.
This case report concentrates on the fatal consequences of the chronic aspects of neuroleptic malignant syndrome (NMS). It is a life-threatening side effect and has been identified since antipsychotics were developed. Efforts to highlight the propensity to develop NMS for those more sensitive to psychotropic medications have been infrequent. Ethnic groups, such as Asians and African Americans, seem to be at higher risk, and therefore clinicians must be hypervigilant of NMS with these groups. Strategies on how to keep a heightened level of awareness about the use of traditional antipsychotic medications with those at risk for NMS are discussed.
本病例报告聚焦于抗精神病药恶性综合征（NMS）慢性阶段的致命后果。它是一种危及生命的副作用，自抗精神病药物研发以来就已被确认。针对那些对精神药物更为敏感的人群，很少有努力去凸显其发生NMS的倾向。亚洲人和非裔美国人等种族群体似乎风险更高，因此临床医生必须对这些群体中的NMS保持高度警惕。本文讨论了对于有NMS风险的人群，如何在使用传统抗精神病药物时保持更高警觉的策略。
